Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 1, Issue 9
1 July 2002
Issue Cover
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

Telomere Shortening and Growth Inhibition of Human Cancer Cells by Novel Synthetic Telomerase Inhibitors MST-312, MST-295, and MST-199 1
Hiroyuki Seimiya; Tomoko Oh-hara; Tsuneji Suzuki; Imad Naasani; Toshiyuki Shimazaki; Katsutoshi Tsuchiya; Takashi Tsuruo
View articletitled, Telomere Shortening and Growth Inhibition of Human Cancer Cells by Novel Synthetic Telomerase Inhibitors MST-312, MST-295, and MST-199 <sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
Apoptosis Induction by 1α,25-Dihydroxyvitamin D3 in Prostate Cancer 1
Meral Guzey; Shinichi Kitada; John C. Reed
View articletitled, Apoptosis Induction by 1α,25-Dihydroxyvitamin D<sub>3</sub> in Prostate Cancer <sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
p53 Mediates DNA Damaging Drug-induced Apoptosis through a Caspase-9-dependent Pathway in SH-SY5Y Neuroblastoma Cells 1
Hongjuan Cui; Allen Schroering; Han-Fei Ding
View articletitled, p53 Mediates DNA Damaging Drug-induced Apoptosis through a Caspase-9-dependent Pathway in SH-SY5Y Neuroblastoma Cells <sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
Induction of Apoptosis in Mesothelioma Cells by Antisurvivin Oligonucleotides
Chunyao Xia; Zhidong Xu; Xiaocheng Yuan; Kazutsugu Uematsu; Liang You; Kai Li; Li Li; Frank McCormick; David M. Jablons
View articletitled, Induction of Apoptosis in Mesothelioma Cells by Antisurvivin Oligonucleotides
Open the PDF for in another window
Flavopiridol and Trastuzumab Synergistically Inhibit Proliferation of Breast Cancer Cells: Association with Selective Cooperative Inhibition of Cyclin D1-dependent Kinase and Akt Signaling Pathways 1
Kongming Wu; Chenguang Wang; Mark D’Amico; Richard J. Lee; Chris Albanese; Richard G. Pestell; Sridhar Mani
View articletitled, Flavopiridol and Trastuzumab Synergistically Inhibit Proliferation of Breast Cancer Cells: Association with Selective Cooperative Inhibition of Cyclin D1-dependent Kinase and Akt Signaling Pathways <sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
Constitutive and Inducible Akt Activity Promotes Resistance to Chemotherapy, Trastuzumab, or Tamoxifen in Breast Cancer Cells
Amy S. Clark; Kip West; Samantha Streicher; Phillip A. Dennis
View articletitled, Constitutive and Inducible Akt Activity Promotes Resistance to Chemotherapy, Trastuzumab, or Tamoxifen in Breast Cancer Cells
Open the PDF for in another window
Enhanced de Novo Ceramide Generation through Activation of Serine Palmitoyltransferase by the P-Glycoprotein Antagonist SDZ PSC 833 in Breast Cancer Cells 1
Hongtao Wang; Armando E. Giuliano; Myles C. Cabot
View articletitled, Enhanced <em>de Novo</em> Ceramide Generation through Activation of Serine Palmitoyltransferase by the P-Glycoprotein Antagonist SDZ PSC 833 in Breast Cancer Cells <sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
Mechanisms of Resistance to 1,3-Bis(2-chloroethyl)-1-nitrosourea in Human Medulloblastoma and Rhabdomyosarcoma 1
Manny D. Bacolod; Stewart P. Johnson; Francis Ali-Osman; Paul Modrich; Nancy S. Bullock; O. Michael Colvin; Darell D. Bigner; Henry S. Friedman
View articletitled, Mechanisms of Resistance to 1,3-Bis(2-chloroethyl)-1-nitrosourea in Human Medulloblastoma and Rhabdomyosarcoma <sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal"><sup>1</sup></a></sup>
Open the PDF for in another window
BCH-1868 [(-)-2-R-dihydroxyphosphinoyl-5-(S)- (guanin-9′-yl-methyl) tetrahydrofuran]: A Cyclic Nucleoside Phosphonate with Antitumor Activity
Lorraine Leblond; Giorgio Attardo; Bettina Hamelin; David Y. Bouffard; Nghe Nguyen-Ba; Henriette Gourdeau
View articletitled, BCH-1868 [(-)-2-R-dihydroxyphosphinoyl-5-(S)- (guanin-9′-yl-methyl) tetrahydrofuran]: A Cyclic Nucleoside Phosphonate with Antitumor Activity
Open the PDF for in another window
Preclinical and Clinical Pharmacodynamic Assessment of L-778,123, a Dual Inhibitor of Farnesyl:Protein Transferase and Geranylgeranyl:Protein Transferase Type-I
Robert B. Lobell; Dongming Liu; Carolyn A. Buser; Joseph P. Davide; Elizabeth DePuy; Kelly Hamilton; Kenneth S. Koblan; Yih Lee; Scott Mosser; Sherri L. Motzel; James L. Abbruzzese; Charles S. Fuchs; Eric K. Rowinsky; Eric H. Rubin; Sunil Sharma; Paul J. Deutsch; Kathryn E. Mazina; Briggs W. Morrison; Lynne Wildonger; Siu-Long Yao; Nancy E. Kohl
View articletitled, Preclinical and Clinical Pharmacodynamic Assessment of L-778,123, a Dual Inhibitor of Farnesyl:Protein Transferase and Geranylgeranyl:Protein Transferase Type-I
Open the PDF for in another window

Advertisement

Breaking
Ribociclib Plus AI Greenlighted for High-Risk Breast Cancer
AACR Releases 14th Annual Cancer Progress Report
Mesothelioma Newest Approved Indication for Pembrolizumab
View more recent articles
Latest News
AMG 193 Safe, Effective in Multiple Cancer Types
STING Immune Pathway Discovery Earns Lasker Prize
Assessing New RAF-Directed Drugs in Melanoma
View more recent articles
Research Watch
The Dynamics of Ductal Tree Remodeling Shape Mammary Field Cancerization
An Age-Associated Increase in Myelopoiesis Promotes Lung Cancer Development
Post-Fast Refeeding Drives Stem Cell Regeneration via Polyamine Metabolism
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept